Schedule 13D ownership disclosure
ENTASIS THERAPEUTICS HLDGS I
Security class unavailable · CUSIP: 293614103
Event date: 2018-09-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,020,748
- Percent of class
- 7.8100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-18-000541
- Form type
- SC 13D
- Filer
- Entasis Therapeutics Holdings Inc.
- CIK
- CIK 1724344
- Filed
- Oct 09, 2018
- Reporting period
- Sep 28, 2018
- Description
- Schedule 13D beneficial ownership